MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fped.2025.1710578

Медицинская библиотека · Frontiers in pediatrics · 2025

Pediatric acute lymphoblastic leukemia relapse and prognosis: key predictors and therapeutic implications.

Chen XiaoYan, Wu LingLing, Kuang CaiYun, Wang JiaYi, Hao WenGe, Jiang Hua, Zhang WeiNa

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Pediatric acute lymphoblastic leukemia (ALL), the most common childhood malignancy, achieves >95% 5-year survival with risk-adapted therapies. Nonetheless, 10%-15% of patients experience relapse, with post-relapse survival <50%. Challenges remain in optimizing minimal residual disease (MRD)-guided strategies and salvage therapies in ALL.

AIMS: This study aimed to identify relapse predictors and assess post-relapse outcomes among 436 pediatric ALL patients treated according to the CCCG-ALL-2015 protocol.

RESULTS

Of the 436 enrolled patients (median age: 3.9 years; 92.4% B-ALL), sixty-four patients (14.7%) relapsed, predominantly with isolated bone marrow involvement (71.9%). Independent predictors included thrombocytopenia at diagnosis (OR = 2.09, P = 0.037), BCR::ABL1(+) (OR = 3.85, P = 0.024), and positive MRD on day 19 (OR = 2.09) and day 46 (OR = 5.73, P < 0.001) of induction therapy. Post-relapse, isolated extramedullary cases showed higher OS (100% vs. 72.9%, P = 0.078) than bone marrow relapses. HSCT significantly improved OS in bone marrow relapse comparing to patients treated with chemotherapy or CAR-T alone (82.6% vs. 38.1%, P = 0.027).

CONCLUSION

Thrombocytopenia at diagnosis, BCR::ABL1(+), and persistent MRD are critical relapse predictors. HSCT remains pivotal for bone marrow relapse. Incorporating platelet counts into risk stratification and optimizing MRD-guided bridging therapies may enhance outcome. Future research should prioritize thrombocytopenia mechanisms and HSCT preconditioning strategies.

Для цитирования: Chen XiaoYan, Wu LingLing, Kuang CaiYun, Wang JiaYi, Hao WenGe, Jiang Hua, Zhang WeiNa. Pediatric acute lymphoblastic leukemia relapse and prognosis: key predictors and therapeutic implications.. Frontiers in pediatrics. 2025. DOI: 10.3389/fped.2025.1710578.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.